标题
Translational nanoparticle engineering for cancer vaccines
作者
关键词
-
出版物
OncoImmunology
Volume 6, Issue 10, Pages e1290036
出版商
Informa UK Limited
发表日期
2017-02-23
DOI
10.1080/2162402x.2017.1290036
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
- (2016) Steven A. Limentani et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites
- (2015) Craig L. Slingluff et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Low-dose cyclophosphamide enhances antigen-specific CD4+ T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma
- (2015) Oliver Klein et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Strategically Localized Dendritic Cells Promote Rapid T Cell Responses to Lymph-Borne Particulate Antigens
- (2015) Michael Y. Gerner et al. IMMUNITY
- Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
- (2015) Robyn Marty-Roix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens
- (2015) Yuchen Fan et al. JOURNAL OF CONTROLLED RELEASE
- Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer
- (2015) Jean-Louis Pujol et al. Journal of Thoracic Oncology
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
- (2015) Kevin J. Kauffman et al. NANO LETTERS
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity
- (2014) Daisuke Muraoka et al. ACS Nano
- 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
- (2014) J. Vansteenkiste et al. ANNALS OF ONCOLOGY
- Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: Effect of charge, fluidity and antigen-to-lipid ratio
- (2014) Mette Hamborg et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
- (2014) Ji-Li Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Nanoparticle-Mediated Combinatorial Targeting of Multiple Human Dendritic Cell (DC) Subsets Leads to Enhanced T Cell Activation via IL-15–Dependent DC Crosstalk
- (2014) Kartik Sehgal et al. JOURNAL OF IMMUNOLOGY
- Microencapsulation of (deoxythymidine)20–DOTAP complexes in stealth liposomes optimized by Taguchi design
- (2014) Shirin Tavakoli et al. JOURNAL OF LIPOSOME RESEARCH
- Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach
- (2014) Joana M Silva et al. Nanomedicine
- Theranostics: An Iron Oxide Nanocarrier for dsRNA to Target Lymph Nodes and Strongly Activate Cells of the Immune System (Small 24/2014)
- (2014) Macarena Cobaleda-Siles et al. Small
- Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
- (2014) Ce Wang et al. VACCINE
- High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine
- (2014) Takuro Saito et al. VACCINE
- Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: An exploratory study
- (2014) Eva Rossmann et al. Human Vaccines & Immunotherapeutics
- In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters
- (2014) Yun Hu et al. Nanoscale Research Letters
- Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo
- (2013) Fumiaki Shima et al. Acta Biomaterialia
- BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide
- (2013) Luis Sanchez-Perez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lineage relationship of effector and memory T cells
- (2013) Nicholas P Restifo et al. CURRENT OPINION IN IMMUNOLOGY
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
- (2013) Shinichi Kageyama et al. Journal of Translational Medicine
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- Cancer Immunotherapy
- (2013) J. Couzin-Frankel SCIENCE
- LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
- (2012) Carl Christoph Schimanski et al. BMC CANCER
- L-BLP25 Vaccine plus Letrozole Induces a TH1 Immune Response and Has Additive Antitumor Activity in MUC1-Expressing Mammary Tumors in Mice
- (2012) N. R. Mehta et al. CLINICAL CANCER RESEARCH
- Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients
- (2012) Simone M. Goldinger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
- (2012) Erika Hamilton et al. Journal of Translational Medicine
- First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients
- (2012) Neil L Berinstein et al. Journal of Translational Medicine
- Raman Microscopy for Noninvasive Imaging of Pharmaceutical Nanocarriers: Intracellular Distribution of Cationic Liposomes of Different Composition
- (2012) T. Chernenko et al. MOLECULAR PHARMACEUTICS
- The big picture on nanomedicine: the state of investigational and approved nanomedicine products
- (2012) Michael L. Etheridge et al. Nanomedicine-Nanotechnology Biology and Medicine
- A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma
- (2012) Lisa M. Ebert et al. PLoS One
- Monoclonal antibody blockade of IL-2 receptor during lymphopenia selectively depletes regulatory T cells in mice and humans
- (2011) D. A. Mitchell et al. BLOOD
- INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
- (2011) Yi-Long Wu et al. BMC CANCER
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination
- (2011) Junji Kawada et al. INTERNATIONAL JOURNAL OF CANCER
- Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study
- (2011) F. Ohyanagi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer
- (2010) Charles Butts et al. Clinical Lung Cancer
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
- (2010) Daniel E. Speiser et al. JOURNAL OF IMMUNOTHERAPY
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
- (2010) J. H. Sampson et al. NEURO-ONCOLOGY
- A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design
- (2009) L. M. Ebert et al. CANCER RESEARCH
- Regulatory T-Cell-Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
- (2009) T. Nicholaou et al. CLINICAL CANCER RESEARCH
- Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant
- (2009) Eugene Maraskovsky et al. IMMUNOLOGY AND CELL BIOLOGY
- Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
- (2009) Yoshiki Shigematsu et al. LUNG CANCER
- Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432
- (2009) Masatoshi Aoki et al. VACCINE
- Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
- (2008) Kazuhide Tsuji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel
- (2008) Shinichi Kageyama et al. CANCER SCIENCE
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells
- (2008) Eynav Klechevsky et al. IMMUNITY
- Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
- (2008) Hisashi Wada et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now